Re­pare paus­es late-stage plans, reshuf­fles pipeline in ef­fort to cut costs

Re­pare Ther­a­peu­tics is slam­ming the brakes on its gy­ne­co­log­ic can­cer as­sets and pri­or­i­tiz­ing ear­li­er-stage can­di­dates as part of a se­ries of changes de­signed to stretch …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER